Trial Profile
Pancreatin in patients with pancreatic exocrine insufficiency due to chronic pancreatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2018
Price :
$35
*
At a glance
- Drugs Pancreatin (Primary)
- Indications Exocrine pancreatic insufficiency; Pancreatitis
- Focus Therapeutic Use
- 05 Jun 2018 Results presented at the Digestive Disease Week 2018
- 26 Nov 2013 New trial record